Biolab, a subsidiary of Integrated Diagnostics Holdings (IDH), has been selected to operate COVID-19 testing stations at Amman's Queen Alia International Airport to enhance passenger health and safety.

Target Information

Biolab, a subsidiary of Integrated Diagnostics Holdings (IDH) in Jordan, has been appointed as the preferred bidder for the operation of testing stations at Amman's Queen Alia International Airport (QAIA). The stations will primarily focus on offering PCR testing for COVID-19 to passengers arriving in Jordan, along with various other diagnostic tests for departing travelers. The collaboration aims to enhance public health safety at one of Jordan's busiest airports and commenced on August 1, 2021.

Founded in 2001 by Dr. Amid Abdelnour and acquired by IDH in 2011, Biolab has established itself as a leading diagnostic provider in Jordan, operating 20 locations across the country. It serves over half a million patients annually and has significantly contributed to managing the COVID-19 crisis by conducting more than 600,000 PCR and antibody tests since the pandemic's onset.

Industry Overview

The healthcare sector in Jordan, particularly the diagnostics industry, has grown increasingly vital due to the ongoing global pandemic. The public's demand for reliable testing solutions has surged as individuals and governments pr